author-photo

Jonathan S. Brammeld

Wellcome Trust Sanger Institute

13

Papers

236

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Abstract 1081: Genome-wide CRISPR screens reveal Hippo pathway activation as a resistance mechanism in BRAF mutant colon cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1100: Gain and loss of function genome-wide CRISPR screens identify Hippo signaling as an important driver of resistance in EGFR mutant lung cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis

2019 Cell
Show All
- Source
- Cite
- Save
Citations (168)
Abstract 1821: Genome-wide genetic screens define the drug resistance landscape of BRAF mutant colon cancer

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Comprehensive pharmacogenomic profiling of malignant pleural mesothelioma identifies a subgroup sensitive to FGFR inhibition.

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (20)
Pathway-based dissection of the genomic heterogeneity of cancer hallmarks' acquisition with SLAPenrich

2018 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Pathway-based dissection of the genomic heterogeneity of cancer hallmarks' acquisition with SLAPenrich

2018 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (14)
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations

2017 Genome Research
Show All
- Source
- Cite
- Save
Citations (19)
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations

2017 Genome Research
Show All
- Source
- Cite
- Save
Citations (8)
Dissecting the genomic heterogeneity of cancer hallmarks' acquisition with SLAPenrich

2017 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)